Award
National Institute on Aging 1R21AG083451-01A1
An investigation of the response of preclinical mouse models of dementia to adropin therapy
Recipient
Saint Louis University, MO, United States
Award Amount
$416,625.00
Ceiling
$416,625.00
Awarded
April 12, 2024
Identifier
1R21AG083451-01A1
The award funds research investigating the effects of adropin therapy on cognitive decline and neurodegeneration in preclinical mouse models of dementia, aiming to develop new treatments for Alzheimer's disease and related disorders.
Description
This project explores a novel neuropeptide, adropin, as a potential treatment for dementia and neurodegenerative diseases associated with aging. The research involves preclinical mouse models to evaluate the effects of adropin on cognitive decline and neurodegeneration.